Golmohammadi Kamran, Jacobs Philip, Sin Don D
Institute of Health Economics, Edmonton, Alberta, Canada.
Lung. 2004;182(3):187-96. doi: 10.1007/s00408-004-3110-2.
Pulmonary rehabilitation has been demonstrated to be efficacious in chronic obstructive pulmonary disease (COPD), however, its cost-effectiveness is largely unknown. The present study determined the cost-effectiveness of a community-based pulmonary rehabilitation program for COPD patients with mild, moderate, and severe disease. We compared the direct costs (in Canadian dollars) and disease-specific quality of life (measured by the St. George's Respiratory Questionnaire, SGRQ) of patients with COPD (N = 210) who enrolled in the rehabilitation program in Edmonton, Canada one year before and after completion of the program. To determine temporal trends in health service utilization between 2000 and 2002 we used similar data from 592 COPD patients from the same region who did not participate in the rehabilitation program. We found that the health status of patients enrolled in the program improved significantly following pulmonary rehabilitation, irrespective of the severity of disease (total SGRQ score improved by 4.85%, p = 0.001). The total direct cost per 100 person-years of follow-up before the program was $122,071 (SE = 29,566); after the program it was $87,704 (SE = 26,146). The average reduction of total costs before and after the program was $34,367 per 100 person-years or approximately $344 per person per year (p = 0.02). Over one-year, pulmonary rehabilitation was associated with decreased health service utilization, reduced direct costs and improved health status of COPD patients. This suggests that pulmonary rehabilitation is cost-effective for patients with relatively high utilization of emergency and hospital-based services.
肺康复已被证明对慢性阻塞性肺疾病(COPD)有效,然而,其成本效益在很大程度上尚不清楚。本研究确定了一项针对轻度、中度和重度COPD患者的社区肺康复计划的成本效益。我们比较了加拿大埃德蒙顿参加康复计划的COPD患者(N = 210)在计划完成前一年和完成后一年的直接成本(以加元计)以及疾病特异性生活质量(通过圣乔治呼吸问卷,SGRQ测量)。为了确定2000年至2002年期间卫生服务利用的时间趋势,我们使用了来自同一地区未参加康复计划的592名COPD患者的类似数据。我们发现,参加该计划的患者在肺康复后健康状况显著改善,无论疾病严重程度如何(SGRQ总分提高了4.85%,p = 0.001)。该计划前每100人年随访的总直接成本为122,071加元(标准误 = 29,566);计划后为87,704加元(标准误 = 26,146)。计划前后总成本的平均降低为每100人年34,367加元,或每人每年约344加元(p = 0.02)。在一年的时间里,肺康复与COPD患者卫生服务利用的减少、直接成本的降低以及健康状况的改善相关。这表明,对于急诊和基于医院服务利用率相对较高的患者,肺康复具有成本效益。